Deadly New TB Strains Expose Drug Need
PARIS — A deadly drug-resistant new strain of tuberculosis on the rise this year has forced scientists to confront a
PARIS — A deadly drug-resistant new strain of tuberculosis on the rise this year has forced scientists to confront a
NEW YORK (Oct. 12, 2006) – The Global Alliance for TB Drug Development (TB Alliance) announced today that it has
New TB Drugs Urgently Needed to Replace Treatments Designed in the 1960s Dallas, Texas/ New York, September 27, 2006 —
FOR IMMEDIATE RELEASE Global Alliance for TB Drug Development Applauds Innovative, International Effort to Fund New Drugs ‘UNITAID’ Announces Funding
Tuberculosis (TB) is the leading infectious killer of people with HIV/AIDS. In some countries of sub-Saharan Africa, more than 75
Tuberculosis is outrunning us. In the last few months, 53 patients in the South African province of KwaZulu-Natal were found
South Africa outbreak may prove impossible to contain. An outbreak of virulent and very drug-resistant tuberculosis in South Africans with
Licensing Executive Society Awards the “Deal of Distinction” Prize for Top Licensing Agreement in the Industry-University-Government Category NEW YORK CITY
The TB Alliance is sponsoring a systematic, preclinical study looking into various drug combinations for the treatment of tuberculosis. The
TB Alliance Applauds Actions by Health Leaders on XDR-TB and Says More Resources are Needed to Speed Development of New